MARVELD1 expression positively correlated with chemotherapy resistance in ovarian cancer [41] and a poor prognosis in gliomas [42], and it was regarded as the genomic instability-derived gene prognostic signature [43]. The gene discussed is MARVELD1; the disease is ovarian cancer.